Clinical trial
Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for…
NCT00048737 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00048737 |
|---|---|
| Title | Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies |
| Official title | Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Biogen Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Leukemia |
| Intervention type | Drug, Procedure |
| Interventions | Zevalin Radioimmunotherapy, Rituximab, Fludarabine, Cyclophosphamide, Allogeneic Stem Cell Transplantation |
| Enrollment | 70 |
| Start date | Oct 1, 2002 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Nov 8, 2002 |
| Last update posted | Jun 13, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: